initial reports of success using periarticular infiltration of high-volume local anaesthetics in TKA, 5 recent open and randomized studies have confirmed that this technique reduces postoperative intensity of pain and consumption of rescue analgesics. 6 -8 This accelerated recovery was attributed to improved walking capacity and less quadriceps impairment. Traditionally, the degree of knee flexion has been used as an outcome measure after TKA to evaluate functional recovery and the success of the type of analgesia used. 2 -9 However, with the need to accelerate hospital discharge and shorten the period of rehabilitation, 10 -12 the capacity to mobilize from a chair with minimal effort and walk a sufficient distance with minimal aid represents a more realistic criterion to assess functioning and independence after TKA. Physical activity is an important aspect of day-to-day life, and walking capacity is a measure of exercise tolerance requiring muscle strength. Walk tests measure the distance walked over a definite time period, with greater distances indicating better performance. The 6 min walk test (6MWT) and the 2 min walk test (2MWT), respectively, reflect endurance and muscle force required to walk effectively. 13 14 Although CFNB and periarticular infiltration have both been associated with superior analgesia and favourable knee flexion compared with systemic opioids, no randomized, double-blind study has yet been performed to compare the effect of these two techniques on postoperative walking capacity and this measure of mobility is assumed to be an index of postoperative recovery. In fact, the only previous randomized study comparing CFNB with periarticular infiltration was not double blinded and did not use standardized measures of walking capacity and physical activity. 15 This prospective, double-blind, randomized, single-centre trial was designed to compare the quality of analgesia offered by CFNB and periarticular infiltration and their impact on 6MWT and 2MWT performance in both the postoperative period and 6 weeks after surgery. The potential for preoperative and immediately postoperative functional walking capacity to predict late recovery was also assessed. In line with the current literature, it was hypothesized that periarticular infiltration of local anaesthetics would improve functional exercise capacity in both the early and the late postoperative period compared with CFNB.
Methods
A prospective, randomized, double-blind, controlled, singlecentre trial was carried out at the McGill University Health Centre (MUHC). The data for this study came from persons undergoing a primary, unilateral, tricompartmental cemented TKA between February 2007 and November 2008. The study was approved by the MUHC Research Ethics Board (GEN#06-026) and all subjects signed a written informed consent form. At the time of study approval, registration in a clinical trials database was not required.
Subjects
Persons were eligible to enter the study if they were over the age of 18 and were referred for TKA secondary to osteoarthritis. Exclusion criteria were: ASA health status class IV-V, history of abnormal liver enzymes, hepatic failure, renal insufficiency, cardiac failure, organ transplant, morbid obesity (BMI.40 kg m 22 ), neuropathic pain, history of stroke or major neurological deficit, sensory and motor disorders in the operated limb, previous drug dependency, chronic use of opioids, allergy to local anaesthetics, inability to walk independently, and inability to comprehend pain assessment. Patients were instructed before surgery in the use of the numerical rating scale (NRS) to assess pain.
Anaesthesia
Standard monitoring (pulse oximeter, ECG, and non-invasive arterial pressure) was applied to all patients on their arrival in the anaesthetic room. No premedication was given. After an i.v. preload with 500 ml of 0.9% NaCl, a spinal block was performed in sitting position with either a 25 or 27 G Whitacre spinal needle inserted at the L2-L3 or L3-L4 intervertebral space. After clear free flow of cerebrospinal fluid, 12.5 mg of racemic 0.5% bupivacaine was administered to achieve sensory block (to cold and pinprick) to the 10th thoracic dermatome or above. Throughout surgery, sedation, if necessary, was achieved with a continuous infusion of propofol. Intravenous normal saline (0.9% NaCl) was administered during the surgery at an hourly rate of 6-8 ml 21 , and intraoperative normothermia (.36.08C) was maintained with warming blankets spread over the exposed part of the body. Hypotension (arterial pressure ,80 mm Hg) was treated with i.v. bolus doses of 100 mg of phenylephrine. Oxygen therapy (30% oxygen mask) was provided to all patients during the first 24 h.
Surgical care
All surgeries were performed by a single surgeon (M.T.). One dose of 2 g of cefazolin (GlaxoSmith Kline, England) was given i.v. 30 min before surgery and then every 8 h for a total of three doses. A pneumatic tourniquet was positioned on the thigh before surgery and inflated to 250 mm Hg. The surgical technique involved approaching the knee through a midline incision with a medial parapatellar arthrotomy. All varus/valgus deformities were then corrected using appropriate soft tissue releases. The anterior cruciate ligament was resected and the posterior cruciate ligament was preserved with a bony island. An intramedullary alignment guide was used to prepare the femur, whereas the proximal tibia was cut using an extramedullary guide. The patella was not everted for exposure or preparation in any case. All patients received a NexGen cruciate retaining TKA with patellar resurfacing (Zimmer, Warsaw, IN, USA). All components were cemented in place using Simplex P cement with tobramycin (Stryker, Rutherford, NJ, USA) that had been pressurized into the cut surfaces using a cement gun.
Analgesic techniques
All patients received a femoral nerve catheter and a periarticular knee catheter. Infiltration of the posterior capsule of the knee to cover popliteal pain A solution containing 100 mg of ropivacaine (50 ml of ropivacaine 0.2%), 0.5 ml of ketorolac (30 mg ml 21 ), and 0.25 ml of epinephrine (1 mg ml 21 ) was injected into the posterior capsule of the knee. This was done after all the bony cuts and before cementing the implants. This allowed wide exposure of the posterior capsule and thereby allowing diffuse infiltration of the capsule. This solution was administered to all patients irrespective of the group, and it was done to make the two groups similar with regard to the popliteal pain which can normally occur in 15 -20% of patients undergoing TKA.
Periarticular and intra-articular infiltration
A second solution containing a total volume of 100 ml of ropivacaine 0.2%, 1 ml of ketorolac (30 mg ml 21 ), and 0.5 ml of epinephrine (1 mg ml 21 ) was prepared to be infiltrated in Group I. An equivalent amount of saline 0.9% was also prepared to be infiltrated in Group F. These solutions were injected into the remainder of the capsule, the cut quadriceps tendon, the patellar ligament and soft tissues surrounding the joint, and the s.c. tissues after closure of the medial parapatellar arthrotomy. At the end of surgery, an intra-articular 3.2 mm catheter tubing (Wound-Evac TM , Microtek, Dominican Republic) was inserted 5 cm proximal to the incision into the distal anterior thigh, penetrating the s.c. tissues, the quadriceps muscle, and the joint capsule, with the catheter tip running along the lateral gutter of the knee joint. Through this catheter, a third solution containing either 50 ml of ropivacaine 0.5% with ketorolac (30 mg ml 21 ) and 0.25 ml of epinephrine (1 mg ml 21 ) or saline 0.9% was infused in Group I and Group F, respectively, over a 2 h period at 24 h after the end of operation. At the end of the infusion, the catheter was immediately removed and a pressure bandage applied.
Randomization
On the morning of surgery, patients were randomized to one of the two groups, continuous femoral nerve block (Group F) and periarticular infiltration (Group I) using computer-generated tables and sealed brown envelopes. The solutions for both femoral and periarticular infiltration were prepared under aseptic conditions. The staff involved in the clinical care (surgeons, anaesthetists, nurses, and physiotherapists) and the patients were not aware of the treatment group assignment.
Multimodal analgesia
At arrival in the post-anaesthesia care unit (PACU), all patients in both groups were connected to a patientcontrolled analgesia (PCA) pump set-up to deliver incremental doses of 1 mg of morphine, with a lockout of 7 min and no background infusion. The PCA was discontinued 48 h after surgery, and all patients received slow-release oxycodone 10 mg p.o. every 12 h. For breakthrough pain with NRS .3, oxycodone 5-10 mg p.o. every 3 h was prescribed for 3 days. Both groups started to receive in the PACU celecoxib 100 mg every 12 h for 5 days and acetaminophen 1 g every 6 h for 5 days. Patients with postoperative nausea and vomiting (PONV) received i.v. ondansetron 2-4 mg and i.v. dymenhydrate (Gravol) 50 mg as needed.
Postoperative care
No patients were placed on a fast track rehabilitation protocol. The patients were visited by the surgical team that was responsible for postoperative care and that was unaware of the results of the clinical or objective assessments. This team recorded daily knee function (flexion, wound bleeding, infection, and pain) and also determined the readiness for discharging patients from hospital according to standard criteria (patients able to ambulate with some assistance, ability to climb stairs, tolerance of solid food, absence of infection, and NRS at rest ,3 out of 10). The i.v. infusion of crystalloids was discontinued on the postoperative day (POD) 1 if no complications (PONV and bleeding) occurred. Full diet was allowed as soon as the patients arrived on the surgical ward. A urinary catheter was not inserted before surgery. Bladder volume was monitored after surgery using a bladder scanner, and if the volume of urine was above 500 ml, patients would receive an in-out bladder catheterization. If they were not able to void after one in -out catheterization, the bladder catheter would be left in situ for 24 h.
Physiotherapy protocol
Under physiotherapist's supervision and in a progressive manner, the following interventions and exercises were undertaken daily (between 12:00 and 15:00 h) while in hospital: body mechanics, bed mobility, out of bed transfer, assisted ambulation, stair training, deep breathing and coughing exercises, flexion and extension of non-operated knee, static quadriceps, and assisted flexion exercises for the operated leg. Maximum knee flexion and pain intensity (NRS 0-10) during knee flexion were recorded. The physiotherapist, in consultation with the surgeon, was also in charge of organizing the discharge either to home or to a rehabilitation centre.
Outcome measures

Analgesia
The quality of postoperative pain relief was estimated by daily consumption of morphine during the first 48 h and the NRS for pain (11-point scale 0-10 where 0 means no pain and 10 extreme pain) at rest, on walking, and on knee maximal flexion for each of the first 3 days, at the time of hospital discharge, and 6 weeks after surgery. The degree of knee flexion was measured by the physiotherapist with a goniometer, and pain intensity during knee assessment was assessed during the early afternoon hours for the first three PODs. The incidence of PONV was recorded for the first 48 h.
Functional walking capacity
The 2MWT and 6MWT were used to assess functional walking capacity. 16 The 2MWT was measured before surgery and in the early afternoon (between 13:00 and 17:00 h) of the first, second, and third PODs to assess muscle strength and the obstacles to walking recovery. The 6MWT was measured before surgery and at 6 weeks after surgery to assess endurance. The distance covered was then recorded in metres. If the patient was unwilling or unable to walk, the reason was recorded for that day. Baseline-predicted 2MWT and 6MWT distance was calculated using gender-specific reference equations for the 6MWT. 17 Physical activity Activity while in hospital was recorded as the total time out of bed either sitting or walking during the first three PODs in a journal by all patients. Also time to first full diet and first walk was recorded. To assess the amount of physical activity before and 6 weeks after surgery, patients were asked to fill the Community Health Activities Model Program for Seniors (CHAMPS) questionnaire. This was developed to evaluate the effectiveness of interventions to increase physical activity in older adults. 18 The CHAMPS has construct validity and been used in surgical patients to assess recovery. 19 Health-related quality of life This was measured by the acute (week recall) SF-12 health survey. 20 Assessment of knee function
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 21 and the Knee Society evaluation 22 were administered before and 6 weeks after surgery.
Data collection
All characteristic and clinical data related to patients' outcome measures (primary, secondary, and intermediate) during the immediate and late postoperative period were collected by a research assistant unaware of the study hypothesis. Length of hospital stay and readmission rate were also recorded, and postoperative complications up to 30 PODs were fully documented.
Power of the study
The primary outcome was morphine consumption during the first 48 postoperative hours. On the basis of the values reported in two separate studies on TKA and comparing periarticular infiltration vs PCA morphine and similarly femoral block vs PCA morphine, 36 patients would be required to detect a significant difference between Group F (n¼18) and Group I (n¼18) .40% in morphine consumption with a power of 80% and an a of 5%. 6 23 To allow for protocol violations or increased variability in data, 40 patients in total were recruited.
Data analysis
Statistical analysis was performed using Stata Version 9.2 software (Stata Corporation, College Station, TX, USA). The clinical data of the population studied are presented in Table 1 , and normally distributed continuous variables were P-value within groups ,0.01 recovery), and the absolute value of 6MWT at 6 weeks (late recovery). Variables significantly related to these measures of recovery in the bivariate analysis, if non-normally distributed, were then transformed to produce normal distributions. Variables that were significant on this initial analysis were entered into multiple linear regression models built with a stepwise approach. This allowed us to identify variables independently related to the two established measures of recovery ( 
Results
Patients and clinical care
The flow of patients through the study is shown in Figure 1 . The patient characteristics and clinical data related to surgery of the two groups were comparable except for a longer duration of surgery in Group F (Table 1) . Two patients, one in each group, had a haematoma in the operative knee joint; however, neither of these was sufficiently severe to require surgical drainage. A second patient in Group I had atrial fibrillation on the POD2 and was treated successfully with medical therapy. No infection occurred. There were no hospital readmissions during the first 30 PODs.
Pain relief
Patients in Group F used less morphine than Group I during the first two PODs (Table 2 ). There was a trend to less pain at rest in the F group, but on walking, the NRS was similar between the two groups. There were also no differences in NRS pain at greatest knee flexion between groups on the first and second PODs. The incidence of PONV was similar in both groups on day 1, but was greater in Group F on day 2 (six out of 20 in Group F vs one out of 20 in Group I, P¼0.037). Fig. 2 ). These changes were not different between the two groups. Seven patients in Group I (35%) and six in Group F (30%) did neither walk nor performed the 2MWT on POD1 for multiple reasons: pain (6) , dizziness (5), tiredness (5), bleeding (2), and swollen knee. All patients walked on days 2 and 3. The number of patients ambulating over 30 m on day 2 in Group I were six out of 20 (30%) and in Group F three out of 20 (15%), and on day 3 were 11 (55%) in Group I and eight (40%) in Group F, with no differences between the two groups. Time out of bed walking during the first two PODs increased significantly in both groups, with Group F spending a significantly longer time walking compared with Group I. Other functional measures (out of bed time sitting and maximal knee flexion) were not different between the two groups.
Late postoperative functional outcome
The preoperative 6MWT was similar in both groups, being approximately the 37% of age-gender appropriate predicted scores (Table 4 ). When repeated 6 weeks after surgery, 6MWT scores increased in Group F (+15.5%) but not significantly in Group I (+8.3%).
Reported amount of physical activity as assessed by CHAMPS showed a significant increase in Group F (+135.7%) but not significantly in Group I (+44.6%) 6 weeks after surgery compared with preoperative values.
The physical component of the SF-12 increased significantly in both groups (+35.0% for Group F and +41.3% for Group I) at 6 weeks compared with baseline. There were no changes in the mental component of the SF-12.
The Knee Society evaluation decreased significantly in both groups 6 weeks after surgery (+64.3% in Group F and +49.3% in Group I); the comparisons between measurements made 6 weeks after surgery showed absolute values significantly higher in Group F (P¼0.05).
Similarly, the changes in WOMAC scores over the first 6 postoperative weeks were statistically significant in both groups (262.1% in Group F and 247.9% in Group I), with absolute values significantly lower in Group F (P¼0.04).
Maximal knee extension improved in both groups at 6 weeks with no difference between the two groups. Maximal knee flexion decreased significantly in Group I (27.8%) but not significantly in Group F (26.0%), with no differences between groups regarding absolute values.
Correlations between perioperative physiological variables and immediate and late post-surgical recovery indicators
Only four and three variables, respectively, for the two functional outcomes were found independently and significantly correlated with the 2MWT and the 6MWT, respectively ( Table 5 ). Body weight, ASA, preoperative 2MWT, and total time out of bed during the first three PODs were the predictors of the immediate recovery of 2MWT. Preoperative 6MWT, ability to walk 24 h after surgery, and total time spent walking during the first three PODs were the independent predictors of the distance covered over 6 min at 6 weeks after surgery.
Discussion
In this double-blind, randomized, controlled trial, CFNB was associated with a significantly reduced postoperative consumption of morphine and a trend to better analgesia compared with periarticular infiltration. In addition, patients in the CFNB group spent more time out of bed walking during the first two PODs. Functional recovery at 6 weeks after surgery was more favourable in the CFNB group which showed a greater improvement in walking capacity, physical activity, and indices of knee function.
The initial findings from non-randomized studies reporting good quality of postoperative analgesia and opioid-sparing effect achieved with periarticular infiltration of local anaesthetics for knee arthroplasty prompted clinicians to conduct randomized, controlled studies comparing this technique with systemic opioids in the context of multimodal analgesia. 5 -8 The positive findings would indicate that such a simple technique could potentially accelerate the recovery process and allow patients to be more mobile after surgery. A recent study comparing the periarticular infiltration technique with femoral block showed the superiority of pain relief and less opioid consumption with periarticular infiltration. 15 This is in contrast with present findings where the use of femoral block was associated with less morphine consumption. Although a direct explanation for this discrepancy cannot be found, comparative analysis of results reveals that no sciatic block was used and the breakthrough administration of morphine was significantly greater than previously used. 6 7 Despite this difference, both the previous and the current studies did use similar anaesthetic regimens for both periarticular infiltration and CFNB, and used a compressed bandage as suggested to help the spread of local anaesthetic in the periarticular area. 8 As a secondary outcome, this study aimed to determine the impact of postoperative analgesia on functional outcome. Beside knee function, we wanted to assess walking capacity and physical activity in the immediate postoperative period and 6 weeks after surgery. The 2MWT was measured to assess muscle force in the leg exerted when walking over a short period of time. 14 24 We did not administer the 6MWT in this acute stage as it was thought that patients would not have been able to walk for such a long period of time. This is evident from the study by Ilfeld and colleagues 25 in which patients walked on average 40 m in 6 min on the second POD, whereas ours walked over 20 m in 2 min.
Functional outcome at 6 weeks after surgery
Traditionally, outcome measures assessing knee function during the postoperative period have been constructed with the intent to assess mainly the range of motions specific to the knee (WOMAC and the Knee Society) 26 27 and the pain associated with it. However, there has been an increasing interest in assessing the capacity to ambulate, as this is dependent upon muscle strength rather than range of motion, and has been shown to be a critical determinant of postoperative outcome after TKA. 28 29 Although distance has been used to determine readiness to discharge, this test has not been standardized and depends on outside influences. In contrast, the walk test is a reliable index of exercise tolerance as it assesses submaximal exercise capacity measured by a distance over a specific time using a standardized protocol. The 6MWT was originally developed to assess the disease progression in patients with chronic respiratory diseases, but more recently, it has been used and validated as a measure of recovery after surgical procedures 24 30 -32 as it integrates all components of functional walking capacity such as balance, speed, and endurance in one measure. It is easy to administer, has construct validity and is sensitive to changes. Nevertheless, it can be influenced by general health status, age, gender, and BMI. In the present study, the CFNB group had a more favourable improvement at 6 weeks not only in the outcome measures associated with mobilization and activity, 6MWT, and CHAMPS, but also with the knee function (WOMAC and the Knee Society). In the CFNB group, the walking distance increased in 6 weeks by 35 m. This change was matched by a 136% increase in physical activity (CHAMPS, kcal kg Such findings not only confirm the positive impact of analgesia on late outcome measures specific to knee function, but also report the beneficial effects on measures of general health and recovery such as physical activity and mobilization. This is the first time that validated outcome measures of functional walking capacity have been assessed in this surgical group.
Correlation between outcome measures and prediction of functional recovery
As a post hoc analysis, in this paper, we also wanted to determine whether, based on the model proposed by Carli and Mayo, 33 the biological and physiological short-term changes would impact on long-term functional outcome. The functional outcome chosen was the improvement in 2MWT between POD1 and POD3 (early recovery) and the absolute value of 6MWT at 6 weeks (late recovery). These are preliminary observations and need to be confirmed in future and adequately powered studies. We found that recovery in 2MWT was positively correlated with all indices of functional activities (walk tests, CHAMPS, and the functional component of the knee society) both in the perioperative period and 6 weeks after surgery and pain intensity during walking (negative correlation). As with the 2MWT, the 6MWT was found to be well correlated at 6 weeks after surgery not only with all the preoperative indices of functional activity, but also with changes in walking time during the first 72 h after surgery. Although the population sample was small and the scope of the present investigation was not to identify those individuals with poor functional scores before surgery and predict the postoperative outcome, the findings might stimulate more research in this area and help to understand how important it is to assess clinical and patient-reported characteristics in order to identify those individuals who are at risk of postoperative poor outcome. 34 These findings would suggest that both the 2MWT and 6MWT could represent reliable indices of both functional exercise capacity and patient perception of knee function, although no correlation was found between the 2MWT and 6MWT and measures of knee function (WOMAC, range of motions, and the clinical component of the Knee Society).
There are some limitations with this study. Although care was taken to blind all techniques, we are aware that injection of ropivacaine to the back of the knee, the insertion of the catheter into the knee and the infusion of saline 0.9% into the femoral nerve are not necessarily the protocols used in the current clinical practice. Both 2MWT and 6MWT measured walking capacity at only one point in time and not throughout the day. In addition, walking represents only one type of activity and not a full range performed on a daily basis. In view of this, we administered the CHAMPS to estimate physical activity at a variety of intensities and frequency based on previous weeks. The CHAMPS before surgery and at 6 weeks were significantly correlated with walking capacity and are consistent with previous reports in surgical 18 and non-surgical populations. 35 36 Another limitation was that we did not assess the impact of the femoral block on the distance covered during 2 min and the ability to ambulate during the first three PODs. The measurement of quadriceps muscle strength would have provided an objective outcome; however, such measurement requires specialized instruments which are not easily portable to be used at the bedside.
Conclusions
Continuous femoral block provided superior analgesia over the periarticular infiltration of high volume of local anaesthetics and was associated with more favourable recovery of walking capacity, physical activity, and knee function. The 2MWT and 6MWT are meaningful outcome measures of exercise capacity and perception of knee functioning after TKA. They are safe to administer and monitor the progression of ambulation in the early postoperative period and are possible indicators of walking ability and physical activity at 6 weeks after surgery. Further studies need to be performed to assess construct validity of these tests in this surgical model over a longer period of rehabilitation and to determine whether the preoperative measurement of walking capacity would help in identifying patients at risk of poor postoperative recovery.
